Mithra Pharmaceuticals will postpone the publication of its Annual Report 2023 (originally scheduled for 30 April 2024) as it was prepared based on a going concern assumption. Instead, considering the recent events, an annual report will be prepared and published for Mithra reflecting a situation "in discontinuity" at a later date, which will be announced in a subsequent communication.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
Apr. 29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.23M | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-11.29% | 33.49B | |
-19.29% | 14.62B | |
-9.03% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- MITRA Stock
- News Mithra Pharmaceuticals S.A.
- Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023